Literature DB >> 14532964

Reduced expression of the regulatory A subunit of serine/threonine protein phosphatase 2A in human breast cancer MCF-7 cells.

Katsuo Suzuki1, Kazuhide Takahashi.   

Abstract

The beta1 subunit of integrin is serine/threonine phosphorylated in growth arrested human breast cancer MCF-7 cells, while it is not in quiescent normal human breast epithelial (HBE) cells. Using the affinity-purified antibodies PB788-9 against the synthetic oligopeptide that contained phosphothreonines corresponding to threonines 788 and 789 on beta1 integrin, beta1 integrin in MCF-7 cells, but not in HBE cells, was found to react with PB788-9. The beta1 integrin immunoprecipitates from HBE cells co-immunoprecipitated the core enzyme of serine/threonine protein phosphatase (PP) 2A, consisting of the regulatory A (PP2A-A) and the catalytic C (PP2A-C) subunits, with the protein phosphatase activity susceptible to okadaic acid (OA), an inhibitor of PP2A and PP1, but not to a PP1 inhibitor. In contrast, beta1 integrin from MCF-7 cells co-immunoprecipitated PP2A-C, but not PP2A-A, with no protein phosphatase activity. Immunoblotting of whole cell lysates revealed that a comparable amount of PP2A-C was present in either HBE or MCF-7 cells, but the amount of PP2A-A was significantly reduced in MCF-7 cells compared to that in HBE cells. The results suggest that the failure of beta1 integrin dephosphorylation at threonines 788 and 789 may be due to a significant reduction in the PP2A-A expression in MCF-7 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532964

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

Review 1.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

2.  Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study.

Authors:  Yu Cheng; Wennuan Liu; Seong-Tae Kim; Jishan Sun; Lingyi Lu; Jielin Sun; Siqun Lilly Zheng; William B Isaacs; Jianfeng Xu
Journal:  Cancer Genet       Date:  2011-07

3.  Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration.

Authors:  Patrick A Kiely; Denise O'Gorman; Ken Luong; Dorit Ron; Rosemary O'Connor
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

4.  Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers.

Authors:  Kathryn G Roberts; Amanda M Smith; Fiona McDougall; Helen Carpenter; Martin Horan; Paolo Neviani; Jason A Powell; Daniel Thomas; Mark A Guthridge; Danilo Perrotti; Alistair T R Sim; Leonie K Ashman; Nicole M Verrills
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

5.  Transcriptional regulation of PP2A-A alpha is mediated by multiple factors including AP-2alpha, CREB, ETS-1, and SP-1.

Authors:  He-Ge Chen; Wen-Jun Han; Mi Deng; Jichao Qin; Dan Yuan; Jin-Ping Liu; Ling Xiao; Lili Gong; Songping Liang; Jian Zhang; Yun Liu; David Wan-Cheng Li
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

6.  Anti-cancer effect of HIV-1 viral protein R on doxorubicin resistant neuroblastoma.

Authors:  Richard Y Zhao; Dong Liang; Ge Li; Christopher W Larrimore; Bernard L Mirkin
Journal:  PLoS One       Date:  2010-07-07       Impact factor: 3.240

7.  WAVE2 Protein Complex Coupled to Membrane and Microtubules.

Authors:  Kazuhide Takahashi
Journal:  J Oncol       Date:  2012-01-18       Impact factor: 4.375

Review 8.  ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia.

Authors:  D Perrotti; P Neviani
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

9.  Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway.

Authors:  P Pandey; P Seshacharyulu; S Das; S Rachagani; M P Ponnusamy; Y Yan; S L Johansson; K Datta; M Fong Lin; S K Batra
Journal:  Br J Cancer       Date:  2013-04-18       Impact factor: 7.640

Review 10.  Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.

Authors:  Priyanka Sandal; Chian Ju Jong; Ronald A Merrill; Jianing Song; Stefan Strack
Journal:  J Cell Sci       Date:  2021-07-06       Impact factor: 5.235

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.